Like other neurological disorders, amyotrophic lateral sclerosis (ALS) involves the NLRP3 inflammasome activation-mediated inflammatory pathway in response to pathogenic proteins, such as β-amyloid and α-synuclein. Here, NLRP3 is linked to nervous system disorder.